ST. AUGUSTINE, Fla. - TelAve -- Dosi, a Health & Fitness app from 3WB Holdings, announced mobile availability on iOS and Android. Built as the world's most capable peptide tracker and personal protocol organizer, Dosi gives people managing complex routines one place for their schedules, logs, reference material, and routine history.

Dosi is available internationally through the Apple App Store and Google Play. Its current public product listings describe features including personal dose logging, schedules and reminders, a body-map record for injection-site rotation, a reconstitution calculator, protocol history, and a 180+ compound reference library.

The platform is designed around personal tracking and educational reference across routine categories represented in Dosi's current public materials, including GLP-1, TRT, HRT, fertility and IVF medication, peptides, growth-hormone routines, nootropics, and longevity-related compounds. For people organizing GLP-1 routines, the app can serve as a semaglutide tracker or tirzepatide tracker. Category coverage is not a medical recommendation, suitability determination, or treatment guidance.

More on TelAve News

• ASTPP Launches Carrier-Grade VoIP Billing Software for Wholesale Telecom Carriers
• CRG Awarded NASA SEWP VI Contracts in Categories B and C
• Heidi G. Villari of The Villari Firm, PLLC Named to Super Lawyers for the Tenth Consecutive Year
• Elevate Your Sneakers With Crep Protect Trek Laces
• Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision

Dosi also includes Ask Dosi, an in-app AI intelligence layer described in its current store listings as a research-informed information feature. Ask Dosi is intended to help users find relevant educational and tracking information inside the product; it is not a clinician, does not diagnose or prescribe, and is not a substitute for qualified healthcare guidance.

"People managing complex routines often end up moving between calendars, notes, screenshots, and spreadsheets," said Dean White, Founder and CEO of Dosi. "We built Dosi to give them one place to organize the information they personally track and bring better context to conversations with their qualified healthcare providers."

Dosi's free tier allows users to start organizing a protocol. Premium plans add expanded product features. The app is intended for informational and organizational use only; it does not provide medical advice, diagnosis, or treatment. Users should consult a qualified healthcare provider regarding medical decisions, prescriptions, dosing, or treatment.

More on TelAve News

• Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
• VoIP Supply Launches CloudSpan: A Brand-Agnostic Platform for PBX Licensing and Hosting Management
• DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
• From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
• U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections

About Dosi: Dosi is a personal protocol-tracking app for iOS and Android, built by 3WB Holdings in St. Augustine, Florida.

Media Contact: Dosi / 3WB Holdings — press@heydosi.com

Website: https://heydosi.com
Press kit: Dosi Press (https://heydosi.com/en/press?utm_source=prlog&utm_medium=press_release&utm_campaign=dosi_cross_platform_availability_2026_07)